Qube Research & Technologies LTD Acrivon Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding ACRV
# of Institutions
53Shares Held
23.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.12MShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0949KShares$00.0% of portfolio